The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy
Journal of Surgical Oncology2014Vol. 110(4), pp. 476–481
Citations Over TimeTop 10% of 2014 papers
Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Kenjiro Imada, Keijiro Kiyoshima, Junichi Inokuchi, Katsunori Tatsugami, Seiji Naito
Abstract
The features of MetS were linked with poorer outcome after radical prostatectomy among Japanese men. Further investigations are needed to determine the effect of improving MetS on prostate cancer prognosis.
Related Papers
- → Biochemical recurrence after radical prostatectomy: what does it mean?(2018)153 cited
- → High prevalence of obesity, dyslipidemia and metabolic syndrome in a rural area in Pakistan(2008)35 cited
- → Management of Dyslipidemia in the Metabolic Syndrome(2007)9 cited
- Study on the symptom of metabolic syndrome in the physical examination of healthy population(2006)
- → The role of dyslipidemia in metabolic syndrome in children and adolescents(2012)